The Lunch Hour with Federal Newswire

The Federal Newswire
  • 5.0 (5)
  • NEWS
  • UPDATED WEEKLY

The Lunch Hour with Federal Newswire covers wide-ranging discussions with the Capitol city's policy movers, shakers, and thinkers. The Lunch Hour provides a unique look at the people behind the policy debates that are moving in DC.

  1. 1H AGO

    Ep. 186 - Faith, Persecution & the Story Behind Faith Under Siege w/Sarah Makin

    Why does religion remain at the center of so many global conflicts — and why do policymakers often ignore it? On this episode of the Federal Newswire Lunch Hour Podcast, host Andrew Langer is joined by Sarah Makin, religious freedom advocate and producer of Faith Under Siege, to explore the role of faith in global conflict, diplomacy, and human rights. Drawing on her experience in government and international advocacy, Makin argues that one of the biggest blind spots in U.S. foreign policy is a failure to understand religion as a core driver of identity, motivation, and conflict. A major theme of the conversation is how authoritarian regimes view faith as a threat — because it represents a source of authority beyond the state. The discussion covers: • Why religion plays a central role in global conflicts • How U.S. diplomacy often misunderstands religious dynamics • Why authoritarian regimes fear people of faith • Religious persecution in China (Uyghurs, Christians, others) • The crisis in Nigeria and the role of extremist ideology • Why religious persecution is a “canary in the coal mine” for genocide • Lessons from Iraq and the Yazidi genocide • The role of faith-based organizations in humanitarian work • Why smaller NGOs often outperform large aid institutions • The importance of religious literacy in foreign policy The conversation also takes a deep look at the war in Ukraine — particularly the often-overlooked issue of religious persecution. Additional topics include: • Russia’s use of the Orthodox Church as a political tool • The myth of Ukrainian religious persecution • Documented attacks on churches, clergy, and faith communities • The targeting of evangelical, Catholic, Jewish, and Orthodox groups • The broader role of faith in Ukrainian society Makin also discusses her film project, Faith Under Siege, a documentary series highlighting the persecution of religious communities in Ukraine under Russian occupation. The project includes both a full-length film and shorter features focused on specific faith groups and stories. The episode closes with a broader reflection: ignoring religion in policy discussions doesn’t eliminate its influence — it simply makes decision-makers less equipped to understand the world. 00:00 — Intro + Sarah Makin joins 01:06 — Why religion drives global conflict 03:13 — U.S. foreign policy blind spots on faith 05:42 — Authoritarian regimes vs people of faith 07:19 — Religious persecution in China and beyond 10:01 — Nigeria crisis and extremist ideology 12:40 — “Canary in the coal mine” for genocide 13:58 — Iraq, Yazidis, and humanitarian work 16:08 — Faith-based NGOs vs large aid systems 23:50 — Ukraine: churches, war, and persecution 26:18 — Russia, the Orthodox Church, and propaganda 33:58 — Faith Under Siege documentary 37:49 — Personal interests + closing Watch Full-Length Episodes: https://www.youtube.com/@Lunchhour_FNW

    40 min

  2. MAY 1

    Ep. 185 - AI Regulation, Free Markets & the Guard Act Debate w/Zach Lilly

    As artificial intelligence rapidly evolves, so does the debate over how — and whether — it should be regulated. On this episode of the Federal Newswire Lunch Hour Podcast, host Andrew Langer is joined by Zach Lilly, Director of Government Affairs at NetChoice, to break down the growing policy battle over AI, free markets, and government oversight. Lilly explains why public fear around AI has surged in recent years — driven in part by decades of pop culture narratives and amplified by ongoing debates over social media and technology policy. He argues that much of today’s AI conversation didn’t start fresh, but instead picked up where earlier tech debates left off. A major focus of the episode is the challenge of regulating a rapidly evolving technology. Lilly warns that traditional legislative approaches struggle to keep pace with AI’s speed of innovation — where tools and capabilities can change week to week. The discussion also covers: • Why AI debates are shaped by pop culture and public perception • The difference between “permissionless innovation” and the precautionary principle • Why free market voices have become less dominant in tech policy debates • How state-level AI regulations are being crafted and marketed • Why some AI laws are framed as “child safety” measures • The risks of one-size-fits-all regulatory approaches • How AI is already improving fields like healthcare and diagnostics • Why rapid innovation makes static regulation difficult • The role of federal vs state governments in AI policy A key part of the conversation focuses on the Guard Act, a proposed federal bill that Lilly describes as a sweeping age verification system disguised as chatbot regulation. He explains how such policies could effectively require identity verification across large portions of the internet, raising concerns about privacy, surveillance, and constitutional rights. Additional topics include: • How AI integration across platforms could expand data collection requirements • The risk of treating all users as potential bad actors • Why government-led AI design could slow innovation • The balance between safety, privacy, and technological progress • Concerns about AI being used as a regulatory enforcement tool • The importance of intellectual and ideological consistency in policymaking The episode also highlights a broader philosophical divide: whether emerging technologies should be allowed to develop freely — with limited intervention — or shaped early through government regulation. At its core, the conversation makes the case that how the U.S. approaches AI policy now will have long-term consequences for innovation, economic growth, and individual liberty. Watch Full-Length Episodes: https://www.youtube.com/@Lunchhour_FNW

    41 min

  3. APR 30

    Ep. 183 - China, Naval Power, and America’s Shipbuilding Crisis w/Brent Sadler

    Naval power has shaped global dominance for centuries — and today, it may determine the outcome of America’s strategic competition with China. On this episode of the Federal Newswire Lunch Hour Podcast, host Andrew Langer sits down with Brent Sadler, Senior Research Fellow for Naval Warfare and Advanced Technology at The Heritage Foundation, to examine how maritime strategy, industrial capacity, and global trade are converging into one of the most critical national security challenges facing the United States. Sadler explains why control of the seas is about far more than military force — it is about controlling supply chains, trade routes, and the flow of global commerce. Drawing from both history and modern strategy, he outlines how China has spent decades building a dominant maritime industrial base, including shipbuilding, port ownership, and logistics networks designed to influence — and potentially control — global trade. A major focus of the conversation is America’s declining shipbuilding capacity and why current policy frameworks, including the Jones Act, have not been sufficient to reverse that trend. Sadler argues that the real issue is not a single law, but a lack of coordinated national strategy, incentives, and long-term industrial focus. The discussion also explores: • Why naval power is central to both economic and military dominance • How China built the world’s largest shipbuilding industry • The strategic importance of ports and global shipping lanes • Why supply chains — not just weapons — define modern conflict • The limitations of the Jones Act and what it gets right (and wrong) • The need for a comprehensive U.S. maritime industrial strategy • How government policy, financing, and regulation shape shipbuilding outcomes • The role of tariffs, trade policy, and industrial incentives • Lessons from the Cold War — and where the U.S. miscalculated with China • Why the U.S. is now in a “new Cold War” with fundamentally different dynamics The conversation also shifts to current global conflicts, including the evolving situation with Iran, and how U.S. military and economic actions there tie into a broader strategy for countering China’s global ambitions. Sadler emphasizes that understanding both America’s vulnerabilities and China’s long-term strategy is essential if the U.S. hopes to rebuild its industrial base, strengthen deterrence, and maintain its position in the global order. 00:00 — Intro + Brent Sadler joins the podcast 01:17 — Background: Naval Academy, Navy career, China policy 02:25 — Why naval power still matters today 03:04 — Historical lessons: sea power and trade control 05:10 — Force projection vs control of global commerce 06:10 — China’s global port strategy explained 07:13 — The “Third Taiwan Crisis” and China’s wake-up call 08:12 — How China built a dominant shipbuilding industry 09:42 — Industrial policy, ports, and supply chain control 10:42 — Could China disrupt global trade flows? 12:16 — The Jones Act explained 13:02 — Why U.S. shipbuilding is still declining 14:44 — What’s missing: incentives, leadership, and strategy 16:00 — “Revolution in Shipping” and policy solutions 18:18 — Bipartisan momentum and the Ships for America Act 19:42 — Trump-era maritime push and executive action 21:00 — Industrial policy vs free market concerns 22:30 — Where the U.S. misread China 24:40 — Economic interdependence and strategic vulnerability 26:00 — COVID, supply chains, and wake-up calls 29:10 — Iran conflict and global strategy implications 31:41 — Military objectives and regime pressure in Iran 33:40 — Why conflicts must be viewed through China strategy 35:16 — Understanding adversaries vs projecting U.S. values 37:51 — Sadler’s backgro Watch Full-Length Episodes: https://www.youtube.com/@Lunchhour_FNW

    46 min

  4. APR 30

    Ep. 184 - Healthcare Costs, Pharma Policy & HSAs: A Market-Based Approach w/Isabelle Marchese

    Why does healthcare keep getting more expensive — and are policymakers making the problem worse? On this episode of the Federal Newswire Lunch Hour Podcast, host Andrew Langer sits down with Isabelle Marchese, Director of Health Policy at Americans for Tax Reform, to break down the real drivers behind rising healthcare costs and the policy decisions shaping the system. Marchese explains how government intervention has distorted basic supply-and-demand dynamics in healthcare — increasing demand without expanding supply — and why that imbalance continues to push costs higher for patients. A major focus of the conversation is the growing push for pharmaceutical price controls, including policies like “most favored nation” pricing and provisions in the Inflation Reduction Act. Marchese outlines the unintended consequences of these approaches, particularly their impact on innovation and long-term drug development. The discussion also covers: • Why healthcare should be viewed as a resource economics problem • How supply and demand imbalances drive rising costs • The real impact of pharmaceutical price controls on innovation • Why fewer new drugs could result from current policies • The long-term value of innovation and generic drug development • How intellectual property protections shape medical breakthroughs • The economic realities of drug development (cost, time, and risk) • Why Health Savings Accounts (HSAs) reduce costs for consumers • How HSAs reconnect patients to healthcare spending decisions • Recent policy changes expanding HSAs — and what’s still needed • The role of tariffs in pharmaceutical policy and supply chains • The risks of overregulation and government “tinkering” • Why ideological consistency matters in healthcare policy debates The conversation also explores a broader theme: how political incentives and short-term thinking often lead to policies that feel popular in the moment but create long-term challenges for innovation, affordability, and access. At its core, the episode makes the case that sustainable healthcare reform requires aligning incentives, expanding supply, and allowing market forces to work — rather than relying on heavy-handed policy interventions. 00:00 — Intro + Isabelle Marchese joins 00:35 — Early interest in politics and healthcare 02:18 — Healthcare as a supply and demand problem 03:28 — Why costs rise when supply doesn’t increase 04:23 — Americans for Tax Reform’s healthcare focus 05:02 — Pharmaceutical policy and price control debates 06:17 — Inflation Reduction Act and drug pricing impacts 07:19 — How price controls affect innovation 08:29 — Why fewer drugs could be developed 09:18 — Generic drugs and long-term cost reductions 10:59 — Economics of drug development explained 12:24 — Why investment depends on recouping costs 13:33 — Ideological consistency in policy debates 15:00 — Political incentives and policy contradictions 17:15 — Health Savings Accounts (HSAs) explained 18:26 — How HSAs lower healthcare costs 19:14 — Vision for expanding HSAs 20:22 — Healthcare vs insurance: key differences 21:57 — Market forces and consumer behavior 22:22 — Recent HSA policy changes 23:22 — Why reform efforts stall 25:21 — Tariffs and pharmaceutical supply chains 26:19 — National security vs economic tradeoffs 27:33 — Free rider problem and global pricing 29:45 — Final thoughts on healthcare reform 31:00 — Outside interests: cooking and food prep 34:59 — Closing Watch Full-Length Episodes: https://www.youtube.com/@Lunchhour_FNW

    36 min

  5. APR 13

    Ep. 182 - Drug Pricing, Generics, and IP Reform w/John Murphy

    Prescription drug prices dominate the headlines — but most Americans rely on medicines that rarely get discussed. On this episode of the Federal Newswire Lunch Hour Podcast, host Andrew Langer sits down with John Murphy, President and CEO of the Association for Accessible Medicines, to unpack the critical — and often overlooked — role that generic drugs and biosimilars play in the U.S. healthcare system. Murphy explains why generics make up nearly 90% of prescriptions in the United States while accounting for only a fraction of total drug spending — and why that imbalance reveals deeper structural issues in how medicines are priced, patented, and brought to market. A major focus of the conversation is the growing tension between pharmaceutical innovation and affordability. Murphy breaks down how the current system of patents and exclusivity — originally designed to balance innovation with competition — has evolved in ways that can delay generic entry and extend high prices far beyond what was originally intended. The discussion also explores: • The difference between statutory exclusivity and patent protection • How “follow-on” patents and minor modifications can extend drug monopolies • Why generic competition is less effective today than in the past • The role of pharmacy benefit managers (PBMs) and rebate structures • How pricing incentives can sometimes favor higher-cost brand drugs over generics • The growing importance of biosimilars — and why the U.S. lags behind Europe • The legal and regulatory barriers slowing biosimilar adoption • Why patent litigation is significantly more complex in the U.S. than abroad • The impact of global conflicts on supply chains, input costs, and drug availability • How shipping, energy costs, and geopolitics affect the generic drug market Murphy also highlights the national security implications of the generic drug industry, arguing that access to affordable antibiotics, anti-infectives, and essential medicines is just as critical as breakthrough innovation. The conversation ultimately raises a central question: how can the United States preserve medical innovation while ensuring that patients have timely access to affordable treatments? 00:00 — Introduction and John Murphy joins the podcast 00:48 — Why generics are the backbone of U.S. medicine 02:29 — Generics vs brand drugs: volume vs spending 04:11 — Innovation, IP protection, and the “virtuous cycle” 05:22 — Statutory exclusivity vs patent protection explained 07:19 — “Evergreening” and follow-on patents 09:24 — Inhalers, delivery systems, and patent extensions 11:10 — Controlled release drugs and market behavior 13:50 — PBMs, rebates, and pricing distortions 16:10 — Real-world example: generics vs high-priced alternatives 17:20 — Why IP reform is central to lowering costs 20:01 — Legal battles over generic entry and Supreme Court case 22:14 — Biosimilars vs generics: what’s the difference? 24:03 — Why Europe leads in biosimilars adoption 26:11 — Patent barriers and manufacturing challenges in the U.S. 28:38 — Quality concerns and global manufacturing realities 31:25 — Supply chain pressures and rising costs 33:00 — National security and the importance of generics 35:55 — Final thoughts and where to learn more Watch Full-Length Episodes: https://www.youtube.com/@Lunchhour_FNW

    38 min

  6. APR 6

    Ep. 180 - Nuclear Power, AI, and the Race to Build America’s Energy Future w/Kevin Kong

    In this episode of the Federal Newswire Lunch Hour Podcast, host Andrew Langer speaks with Kevin Kong, founder and CEO of Everstar, about why America’s energy future depends on nuclear power — and why the time to move is now. Kong explains Everstar’s mission to use AI to accelerate nuclear deployment by tackling one of the industry’s biggest bottlenecks: the permitting, compliance, and regulatory process. He argues that nuclear is the only energy source that is dense, reliable, and clean enough to power the next great leap in human progress — including the massive electricity demands coming from AI, data centers, advanced industry, and future economic growth. The conversation explores why America has fallen behind in nuclear development, how decades of regulatory buildup have made projects too expensive and too slow, and why China is rapidly pulling ahead by building reactors at scale. Kong makes the case that the United States needs a full national push — across government, industry, and manufacturing — to rebuild domestic nuclear capacity and reclaim leadership in the technologies that will shape the next century. The discussion also covers: • Why AI demand is making grid expansion an urgent national priority • How advanced reactors, small modular reactors, and microreactors could change deployment • Why existing U.S. reactors may be the fastest source of additional nuclear power • The role of permitting reform, NRC reform, DOE pathways, and congressional action • Why nuclear export capability is also a geopolitical competition with China and Russia • How America can return to being a nation of builders, engineers, and energy abundance This is a wide-ranging conversation about nuclear innovation, regulatory reform, energy security, AI infrastructure, and why America cannot afford to keep falling behind. 00:00 — Introduction and Kevin Kong joins the podcast 01:20 — Everstar’s mission and why nuclear matters 02:27 — Energy abundance and the next leap for humanity 03:06 — Why modern nuclear is safer than people think 05:19 — AI, data centers, and exploding electricity demand 08:11 — Small modular reactors and microreactors explained 10:56 — The fastest path: more power from existing reactors 11:51 — How Everstar uses AI to tackle regulatory bottlenecks 13:09 — The paperwork problem and why nuclear takes so long 15:50 — Risk, regulation, and the politics of nuclear power 19:38 — Why younger generations are more pro-nuclear 21:40 — China, Korea, and the global nuclear export race 25:57 — DOE, NRC, and what government needs to fix 29:03 — Why America needs a full national nuclear push 33:22 — Kevin Kong’s background and what drives his work 36:30 — Where to follow Everstar and closing thoughts Watch Full-Length Episodes: https://www.youtube.com/@Lunchhour_FNW

    38 min

  7. APR 6

    Ep. 181 - Deregulation, AI, and the Hidden Cost of Regulation w/ Patrick McLaughlin

    Regulation shapes nearly every part of the U.S. economy — but what happens when decades of rules pile up without being revisited? On this episode of the Federal Newswire Lunch Hour Podcast, host Andrew Langer sits down with Patrick McLaughlin, Research Fellow at the Hoover Institution, to examine how regulation, deregulation, and emerging technologies like AI are reshaping the relationship between government and the economy. McLaughlin breaks down the current push to roll back existing regulations and explains why focusing on “old rules” may matter more than stopping new ones. He also outlines how regulatory accumulation impacts productivity, investment, and long-term economic growth — and why even modest changes today can compound into significant economic gains over time. The conversation then shifts to structural issues inside the regulatory system itself, including whether the Administrative Procedure Act is overdue for reform and how recent legal shifts following the end of Chevron deference could reshape the balance of power between Congress and federal agencies. The episode also explores: • Whether AI will make regulatory compliance easier — and what that means for future regulation • The risks of “frictionless regulation” and the growth of the administrative state • Why old regulations should be regularly reexamined instead of endlessly accumulating • The real-world economic impact of regulatory buildup on productivity and growth • How deregulation can create compounding long-term economic gains The discussion also takes a close look at the proposed Railway Safety Act, questioning whether new regulations actually improve safety or simply add cost and complexity. McLaughlin explains how certain mandates — like minimum crew size requirements — may not deliver the intended safety benefits and could instead limit innovation, increase costs, and reduce efficiency across the transportation sector. Drawing on new research, he connects transportation policy to the broader economy, showing how regulatory decisions in one sector can ripple outward — affecting prices, productivity, and economic growth nationwide. This is a data-driven, big-picture conversation about regulation, innovation, and the long-term consequences of policy decisions that often go unquestioned. 00:00 — Intro and Patrick McLaughlin joins the show 01:13 — REINS Act and Trump-era deregulation overview 03:09 — Cutting old regulations vs stopping new ones 04:47 — Are deregulation savings real? 06:23 — How regulation impacts productivity and economic growth 07:43 — AI and the future of regulatory compliance 10:01 — Does easier compliance lead to more regulation? 11:10 — Why process reform matters more than friction 12:26 — Should the Administrative Procedure Act be updated? 14:39 — Reexamining old regulations and regulatory buildup 16:40 — Post-Chevron world and vague statutory authority 19:02 — Scope of regulatory overreach (37% estimate) 23:53 — The Railway Safety Act explained 25:00 — Why more regulation doesn’t always improve safety 27:27 — Deregulation and rail safety improvements since 1980 29:14 — Who actually benefits from new regulation? 30:54 — Innovation, transportation, and economic growth 33:05 — How regulation increases costs and reduces output 37:11 — Unintended consequences of regulation 40:39 — How Patrick McLaughlin got into regulatory economics 43:19 — Closing thoughts and where to follow Patrick Watch Full-Length Episodes: https://www.youtube.com/@Lunchhour_FNW

    44 min

  8. MAR 23

    Ep. 179 - Healthcare Fraud, Medicaid Laundering & Free-Market Fixes w/Dr. Brian Blase

    Andrew Langer interviews Dr. Brian Blase, President and Founder of Paragon Health Institute, a leading conservative healthcare think tank focused on market-based reforms.  They dive into America’s healthcare crisis: massive fraud in Medicaid ($200B+ annual waste via provider taxes and accounting gimmicks) and Obamacare subsidies ($30B+ in improper payments from zero-premium plans, ghost enrollees, broker incentives). Brian explains how government subsidies inflate demand while price controls and regulations restrict supply—driving hospital prices 3x faster than inflation since 2000 and crowding ERs with non-emergent care.  The conversation covers primary care shortages (Medicare payment distortions favoring specialists), the myth of “free” coverage, prescription drug pricing (retrospective vs. prospective Most Favored Nation), and solutions: deregulate to expand choices (HSAs, catastrophic plans, nurse practitioners, immigration for doctors), end corporate welfare in Medicaid, and prioritize patient-driven innovation over political allocation.  Perfect for policymakers, patients, and anyone frustrated with high costs and bureaucracy. Visit paragoninstitute.org for research and newsletters. Follow @Brian_Blase on X. Subscribe on YouTube, Apple Podcasts, Spotify. Follow us on X @TheLunchHourPod, TikTok, and more! 00:00:04 - Welcome to Federal Newswire Lunch Hour Podcast00:00:14 - Host Andrew Langer Opening & Social Plugs00:01:19 - Guest Intro: Dr. Brian Blase & Paragon Health Institute00:02:11 - Paragon’s Mission: Free-Market Health Policy Focus00:03:15 - Healthcare vs. Insurance vs. Health Distinctions00:04:04 - Supply/Demand Distortions & Hospital Price Inflation00:06:09 - Primary Care Shortage & Medicare Payment Bias00:07:17 - Congressional Testimony on Subsidy Enhancements00:08:32 - Expanding Choices: HSAs, Catastrophic Plans, Deregulation00:10:05 - ACA Outcomes: Medicaid Expansion & ER Overuse00:11:04 - Subsidies Drive Higher Prices & Deficits00:12:22 - Medicaid as Corporate Welfare: Provider Tax Schemes00:13:33 - Medicaid Fraud Scale: ~$200B Annual Waste00:15:00 - Obamacare Subsidy Fraud: Zero-Premium Incentives00:16:00 - Broker Schemes & Automatic Enrollment Abuse00:17:27 - Non-Utilization Rates & Improper Income Claims00:19:31 - Prescription Drugs: Generics vs. Brand Pricing00:20:47 - Most Favored Nation: Retrospective vs. Prospective00:22:00 - Closing Thoughts on Market Innovation00:29:38 - How to Follow Paragon & Brian Blase00:30:16 - Episode Outro & ThanksWatch Full-Length Episodes: https://www.youtube.com/@Lunchhour_FNW

    31 min
See All (214)

Ratings & Reviews

5
out of 5
5 Ratings

About

The Lunch Hour with Federal Newswire covers wide-ranging discussions with the Capitol city's policy movers, shakers, and thinkers. The Lunch Hour provides a unique look at the people behind the policy debates that are moving in DC.

Information

You Might Also Like